Ref Number
B07-00098
Professional Expertise
Research and Research Support
Department
VP: Health (B07)
Location
London
Working Pattern
Full time
Salary
£39,508 - £47,355
Contract Type
Fixed-term
Working Type
Hybrid (20% - 80% on site)
Available For Secondment
No
Closing Date
12-Jun-2023
UCL Translational Research Group (TRO)
Built on over 10 years of outstanding delivery, the UCL Translational Research Office (TRO) provide practical support to researchers across the university. From project management and translational funding support to initiating strategic collaborations both internally and with industry partners, the TRO's passion, skills and experience are applied to accelerate patient access to medical innovation.
Eisai
Eisai is one of the world's leading research and development (R&D) based pharmaceutical companies. Eisai defines its corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," its human health care (hhc) philosophy.
Eisai concentrates its R&D activities in three key areas:
- Neuroscience, including Alzheimer's disease, Parkinson’s disease, epilepsy, pain and weight loss
- Oncology, including anticancer therapies; tumour regression, tumour suppression, antibodies, etc.
- Vascular/Immunological reaction including thrombocytopenia, rheumatoid arthritis, psoriasis, and inflammatory bowel disease
UCL-Eisai Collaboration
UCL has a major collaboration with Eisai, one of the world's leading research and development (R&D) based pharmaceutical companies. The UCL-Eisai collaboration aims to discover and develop novel therapeutic agents for the treatment of neurological diseases such as Alzheimer’s disease, Parkinson’s disease and other related neurodegenerative disorders. The alliance brings together the strengths of both organizations: UCL providing its world-class early-stage translational research and Eisai providing its drug discovery and development expertise.
We are looking to recruit a scientist to a laboratory-based role which is central to research activities within the UCL-Eisai collaboration. The successful candidate will be expected to provide theoretical and practical expertise in determining the validity, tractability and translatability of novel targets for the treatment of neurodegenerative disease.
Being ideally positioned between world-class early-stage translational research and cutting-edge drug development, the post-holder will have the unique opportunity to work collaboratively with the TIG, Principal Investigators, and scientists at both UCL and Eisai to consolidate the multi-disciplinary expertise from both organisations.
Effective delivery will depend upon the ability to plan and organise effectively and communicate with a wide range of UCL and Eisai partners. The role holder will be expected to make significant intellectual contributions to the progression of projects.
The post will be based within one of the laboratories within the UCL Life and Medical Sciences. The successful candidate may be required to conduct some work at Eisai facilities based in Hatfield, UK.
Post is funded for two years in the first instance.
The role requires an individual with a sound knowledge and experience of molecular and cellular biology with strong focus on neurodegeneration.
In particular, we are looking for a researcher with scientific/technical versatility and flexibility, as evidenced by hands-on experience in a variety of techniques including, for example: molecular biology and biochemistry, assay development (e.g. absorbance, fluorescence, FRET) and optimisation, cell and tissue fractionation, protein purification, bacterial transformation, cell culture systems and disease models, transfections and viral transductions, luciferase assays and other reporter-based reads, western-blotting and fluorescence microscopy.
The post-holder will work closely with colleagues in the TIG, the UCL Translational Research Office (TRO), Principal Investigators from across UCL, and scientists at Eisai.
As well as the exciting opportunities this role presents, we also offer some great benefits some of which are below:
- 41 Days holiday (27 days annual leave 8 bank holiday and 6 closure days)
- Additional 5 days’ annual leave purchase scheme
- Defined benefit career average revalued earnings pension scheme (CARE)
- Cycle to work scheme and season ticket loan
- Immigration loan
- Relocation scheme for certain posts
- On-Site nursery
- On-site gym
- Enhanced maternity, paternity and adoption pay
- Employee assistance programme: Staff Support Service
- Discounted medical insurance
Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more.
As London’s Global University, we know diversity fosters creativity and innovation, and we want our community to represent the diversity of the world’s talent. We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong. We therefore particularly encourage applications from candidates who are likely to be underrepresented in UCL’s workforce. These include people from Black, Asian and ethnic minority backgrounds; disabled people; LGBTQI+ people; and for our Grade 9 and 10 roles, women.